Document is current
Any future updates will be listed below
-
Authors
Montag, Christian
Dagum, Paul
Hall, Brian J.
Elhai, Jon D.
- License Information
-
More Information
Article History
Received: 10 October 2021
Accepted: 23 November 2021
First Online: 4 January 2022
Declarations
:
: None. Nevertheless, for reasons of transparency, the following is reported. CM mentions that he has received (to Ulm University and earlier University of Bonn) grants from agencies such as the German Research Foundation (DFG). CM has performed grant reviews for several agencies; has edited journal sections and articles; has given academic lectures in clinical or scientific venues or companies; and has generated books or book chapters for publishers of mental health texts. For some of these activities he received royalties, but never from gaming or social media companies. CM mentions that he is part of a discussion circle (Digitalität und Verantwortung: ExternalRef removed) debating ethical questions linked to social media, digitalization and society/democracy at Facebook. In this context, he receives no salary for his activities. Finally, he mentions that he currently also functions as independent scientist on the scientific advisory board of the Nymphenburg group. This activity is financially compensated. At the moment he also receives funding from a research project on digital phenotyping by Mindstrong Health, Mountain View, CA, USA. JDE notes that he receives royalties for several books published on posttraumatic stress disorder (PTSD); is a paid, full-time faculty member at University of Toledo; occasionally serves as a paid, expert witness on PTSD legal cases; and receives research funding from the US National Institutes of Health. PD is the founder of Mindstrong Health, a company developing digital phenotyping products for mental healthcare delivery. He served as its Chief Executive Officer from its founding in 2013 through October 2019 and was awarded five US patents on digital phenotyping and digital biomarkers. PD is currently co-founder and CEO of Applied Cognition developing diagnostic and therapeutic solutions for Alzheimer’s disease. PD owns stock in Mindstrong Health and in Applied Cognition.
